TALIANI, SABRINA
 Distribuzione geografica
Continente #
NA - Nord America 12.381
EU - Europa 6.921
AS - Asia 2.309
AF - Africa 266
OC - Oceania 58
SA - Sud America 13
Continente sconosciuto - Info sul continente non disponibili 1
Totale 21.949
Nazione #
US - Stati Uniti d'America 11.984
IT - Italia 3.093
SE - Svezia 1.213
CN - Cina 984
DE - Germania 707
BG - Bulgaria 549
SG - Singapore 447
CA - Canada 392
GB - Regno Unito 294
AT - Austria 288
TR - Turchia 287
VN - Vietnam 272
FI - Finlandia 183
UA - Ucraina 176
IN - India 110
RU - Federazione Russa 102
CI - Costa d'Avorio 101
FR - Francia 100
HK - Hong Kong 94
NG - Nigeria 83
JP - Giappone 67
SN - Senegal 61
CH - Svizzera 59
AU - Australia 56
BE - Belgio 49
NL - Olanda 25
CZ - Repubblica Ceca 17
PL - Polonia 15
KR - Corea 12
BR - Brasile 10
EG - Egitto 10
ES - Italia 9
IR - Iran 9
BJ - Benin 7
GR - Grecia 6
PT - Portogallo 6
DK - Danimarca 5
HU - Ungheria 5
ID - Indonesia 5
IE - Irlanda 5
PK - Pakistan 4
RO - Romania 4
BF - Burkina Faso 3
HR - Croazia 3
IL - Israele 3
TW - Taiwan 3
CL - Cile 2
EE - Estonia 2
JO - Giordania 2
MX - Messico 2
NZ - Nuova Zelanda 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BN - Brunei Darussalam 1
CO - Colombia 1
CY - Cipro 1
DZ - Algeria 1
EU - Europa 1
GE - Georgia 1
GL - Groenlandia 1
JM - Giamaica 1
KZ - Kazakistan 1
LI - Liechtenstein 1
LK - Sri Lanka 1
LT - Lituania 1
MC - Monaco 1
MD - Moldavia 1
MY - Malesia 1
PA - Panama 1
PS - Palestinian Territory 1
SI - Slovenia 1
Totale 21.949
Città #
Woodbridge 1.761
Ann Arbor 1.492
Houston 1.303
Serra 1.183
Fairfield 1.039
Chandler 1.030
Ashburn 671
Milan 613
Sofia 549
Seattle 420
Wilmington 392
Beijing 380
Ottawa 370
New York 356
Cambridge 326
Izmir 279
Boardman 274
Princeton 264
Vienna 251
Jacksonville 246
Lawrence 220
Singapore 200
Nanjing 177
Medford 175
Des Moines 152
Dong Ket 147
London 145
Frankfurt am Main 135
Rho 129
Dearborn 102
Abidjan 101
Hong Kong 89
Lagos 83
Bremen 75
Rome 74
Pisa 66
Dakar 61
Nanchang 58
Los Angeles 56
San Diego 56
Bern 54
Brussels 49
Redwood City 49
Boulder 48
Ogden 48
Florence 46
Chicago 45
Kunming 44
Jüchen 41
Sydney 40
Pune 36
Hebei 35
Changsha 34
Shenyang 33
Tianjin 30
Hefei 29
Düsseldorf 27
Nürnberg 27
San Jose 24
Alessandria 23
Livorno 23
Norwalk 23
Falls Church 22
Pistoia 22
Jiaxing 21
Pessac 21
Auburn Hills 19
Hangzhou 18
Lancaster 18
Washington 18
Toronto 16
Cascina 15
Dallas 15
Lucca 14
San Francisco 14
Santa Margherita Ligure 14
Aversa 13
Orange 13
Phoenix 13
Guangzhou 12
Helsinki 12
Talence 12
Warsaw 12
Vercelli 11
Vicopisano 11
Brno 10
Council Bluffs 10
Hyderabad 10
Citta 9
Marseille 9
Paris 9
Amsterdam 8
Erlangen 8
Jinan 8
Massa 8
Melbourne 8
Santa Clara 8
Scafati 8
Cotonou 7
Edinburgh 7
Totale 16.791
Nome #
1,2-Benzisothiazole Derivatives Bearing 4-, 5-, or 6-Alkyl/arylcarboxamide Moieties Inhibit Carbonic Anhydrase Isoform IX (CAIX) and Cell Proliferation under Hypoxic Conditions 317
TSPO ligand residence time influences human glioblastoma multiforme cell death/life balance 252
Apoptosis Therapy in Cancer: The First Single-molecule Co-activating p53 and the Translocator Protein in Glioblastoma 216
N, N-Dialkyl-2-phenylindol-3-ylglyoxylamides.A new class of potent and selective ligands at the Peripheral benzodiazepine receptor 204
Benzofuroxane Derivatives as Multi Effective Agents for the Treatment of Cardiovascular Diabetic Complications. Synthesis, Functional Evaluation, and Molecular Modeling Studies 200
Bax Activation Blocks Self-Renewal and Induces Apoptosis of Human Glioblastoma Stem Cells 185
Exploiting the Pyrazolo[3,4-d]pyrimidin-4-one ring system as a useful template to obtain potent adenosine deaminase inhibitors, 181
Allosteric modulators of human A2B adenosine receptor. 180
Iminothioethers as Hydrogen Sulfide Donors: From the Gasotransmitter Release to the Vascular Effects 179
[1,2,4]Triazino[4,3-a]benzimidazole Acetic Acid Derivatives: a New Class of Selective Aldose Reductase Inhibitors 178
[1,2,4]Triazino[4,3-a]benzimidazole Acetic Acid Derivatives: A New Class of Selective Aldose Reductase Inhibitors 169
3-Aryl[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-ones: A New Class of Selective A1 Adenosine Receptor Antagonists 167
Deepening the Topology of the Translocator Protein Binding Site by Novel N,N-Dialkyl-2-arylindol-3-ylglyoxylamides 166
3-aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-ones: Tricyclic heteroaromatic derivatives as a new class of benzodiazepine receptor ligands 165
TSPO ligand residence time: a new parameter to predict compound neurosteroidogenic efficacy 163
TSPO PIGA ligands promote neurosteroidogenesis and human astrocyte well-being 162
Identification of Anxiolytic/Nonsedative Agents among Indol-3-ylglyoxylamides Acting as Functionally Selective Agonists at the γ-Aminobutyric Acid-A (GABAA) α2 Benzodiazepine Receptor 161
The Alpha Keto Amide Moiety as a Privileged Motif in Medicinal Chemistry: Current Insights and Emerging Opportunities 161
G-Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitors: Current Trends and Future Perspectives. 159
Arylthioamides as H2S Donors:l-Cysteine-Activated Releasing Properties and Vascular Effects in Vitro and in Vivo 152
Drug-target Residence Time: a key parameter in glial responses to TSPO ligands 149
Synthesis of a Novel Purine-Containing Heterocyclic Ring System: 8,10-Dimethylindolo[2',3':5,6][1,2,4]triazino[4,3-f]purine-9,11(8H,10H,13H)dione 147
TSPO-ligands prevent oxidative damage and inflammatory response in C6 glioma cells by neurosteroid synthesis 146
Refinement of Structure-activity Relationships of the Triazinobenzimidazole A1AR Antagonists 144
Residence Time (RT), a new parameter to predict neurosteroidogenic efficacy of Translocator Protein (TSPO) ligands: N,N-dialkyl-2-arylindol-3-ylglyoxylamides, a case study 144
Geometrically Constrained Analogues N-Benzylindolylglyoxylylamides: [1,2,4]Triazino[4,3-a]benzimidazol-4(10H)-one Derivatives as Potential New Ligands at the Benzodiazepine Receptor. 143
5-Amino-2-phenyl[1,2,3]triazolo[1,2-a][1,2,4]benzotriazin-1-one: a Versatile Scaffold to Obtain Potent and Selective A3 Adenosine Receptor Antagonists 143
2-(Benzimidazol-2-yl)quinoxalines: A Novel Class of selective Antagonists at Human A1 and A3 Adenosine Receptors Designed by 3D Database Searching 141
11C-ER176, a radioligand for 18-kDa translocator protein, has adequate sensitivity to robustly image all three affinity genotypes in human brain 140
Benzo[d]isothiazoles and Matrix Metalloproteinases. Searching for Novel and Selective Inhibitors of MMP9 138
Recent Advances in the Development of Dual Topoisomerase I and II Inhibitors as Anticancer Drugs 138
3-(Fur-2-yl)-10-(2-Phenylethyl)-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one, a Novel Adenosine Receptor Antagonist with (2A)-Mediated Neuroprotective EffeCTS 136
Modulation of A2B Adenosine Receptor by 1-Benzyl-3-ketoindole Derivatives 136
Long Residence Time at the Neurosteroidogenic 18 kDa Translocator Protein Characterizes the Anxiolytic Ligand XBD173 136
“Synthesis and antiproliferative evaluation of new substituted Benzothiopyrano[4,3-c] condensed ring systems” 134
Benzothiopyranoindole-Based Antiproliferative Agents: Synthesis, Cytotoxicity, Nucleic Acids Interaction, and Topoisomerases Inhibition Properties. 134
Targeting the 18-kDa translocator protein: Recent perspectives for neuroprotection 134
Sulfonamides incorporating heteropolycyclic scaffolds show potent inhibitory action against carbonic anhydrase isoforms I, II, IX and XII 134
Osteoblast differentiation and survival: A role for A2B adenosine receptor allosteric modulators. 132
Medicinal chemistry of indolylglyoxylamide TSPO high affinity ligands with anxiolytic-like effects 130
Long lasting inhibition of Mdm2-p53 interaction potentiates mesenchymal stem cell differentiation into osteoblasts 130
Novel N(2)-Substituted Pyrazolo[3,4-d]pyrimidine Adenosine A(3) Receptor Antagonists: Inhibition of A(3)-Mediated Human Glioblastoma Cell Proliferation (dagger) 129
Modulation of A2B adenosine receptor by 1-benzyl-3-ketoindole derivatives 129
p53 Functional Inhibitors Behaving Like Pifithrin-β Counteract the Alzheimer Peptide Non-β-amyloid Component Effects in Human SH-SY5Y Cells. 128
"2-Phenyl[1,2,3]triazole[1,2-a][1,2,4]triazin-1,5(6H)-dione: a derivative of a new tricyclic heteroaromatic system with high affinity at the benzodiazepine receptor" 126
Synthesis of Pyrimido[1,2-a]benzimidazol-4(10H)-one Derivatives and Evaluation of their Interactions with DNA 126
Phenylpyrazolo[1,5-a]quinazolin-5(4H)-one: a suitable scaffold for the development of non-camptothecin Topoisomerase I (Top1) inhibitors 126
The Anxiolytic Etifoxine Binds to TSPO Ro5-4864 Binding Site with Long Residence Time Showing a High Neurosteroidogenic Activity 125
An update into the medicinal chemistry of translocator protein (TSPO) ligands 125
Studies in search for selective ligands for GABAA/BzR receptor subtypes: synthesis and biological evaluation of 4'-modified N-(benzyl)indol-3-ylglyoxylamides 124
Novel Potent and Selective Human Adenosine A3 Receptor Antagonists Containing the Pyrazolo[3,4-d]pyrimidine Ring System. Synthesis and Biological Evaluation 123
A1 adenosine receptor antagonists, 3-aryl[1,2,4]triazino[4,3-a]benzimidazol-4-(10H)-ones (ATBIs) and N-alkyl and N-acyl-(7-substituted-2-phenylimidazo[1,2-a][1,3,5]triazin-4-yl)amines (ITAs): different recognition of bovine and human binding sites 123
Translocator protein ligands as promising therapeutic tools for anxiety disorders 123
Structure-Based Optimization of Tyrosine Kinase Inhibitor CLM3. Design, Synthesis, Functional Evaluation, and Molecular Modeling Studies. 122
Synthesis and Biological Evaluation of 4-Phenylquinazoline-2-carboxamides Designed as a Novel Class of Potent Ligands of the Translocator Protein 121
Medicinal chemistry of indolylglyoxylamide GABAA/BzR high affinity ligands: identification of novel anxiolytic/non sedative agents 121
Allosteric Modulators for Adenosine Receptors: An Alternative to the Orthosteric Ligands 120
Synthesis of New Heterocyclic Ring Systems via [1,3,5]Triazino[1,2-a]benzimidazole Derivatives 119
Acetic acid aldose reductase inhibitors bearing a five-membered heterocyclic core with potent topical activity in a visual impairment rat model 119
Novel Pyrazolo[3,4-d]pyrimidine Derivatives as ATP-competitive Inhibitors of the Epidermal Growth Factor Receptor Protein Tyrosine Kinase 117
Characterization of a new fluorescent irreversible ligand to translocator protein (18 kDa) 117
Tertiary amides with a five-membered heteroaromatic ring as new probes for the translocator protein 117
Structure-Based Lead Optimization and Biological Evaluation of BAX Direct Activators as Novel Potential Anticancer Agents. 116
Pyrido[1,2-a]pyrimidin-4-one derivatives as a novel class of selective aldose reductase inhibitors exhibiting antioxidant activity 116
Structural requirements to obtain highly potent and selective 18 kDa Translocator Protein (TSPO) ligands 116
Naphtho[1,2-d]isothiazole Acetic Acid Derivatives as a Novel Class of Selective Aldose Reductase Inhibitors 115
Investigation of new 2-aryl substituted Benzothiopyrano[4,3-d]pyrimidines as kinase inhibitors targeting vascular endothelial growth factor receptor 2 115
H2S-RELEASING PROPERTIES OF NEW THIOAMIDE, IMINOTHIOETHER AND ISOTHIOCYANATE DERIVATIVES 114
Modulation of PAR(1) signaling by benzimidazole compounds 113
Genetic analysis of dTSPO, an outer mitochondrial membrane protein, reveals its functions in apoptosis, longevity, and Ab42-induced neurodegeneration 113
Pyrazolo[3,4,-d]pyrimidine-4-one Derivatives as Novel and Potent Inhibitors of Adenosine Deaminase 111
An irreversible ligand of the 18 kDa Translocator Protein induces rapidly ΔΨm collapse and activates apoptosis in human glioblastoma multiforme cells. 111
Novel fluorescent triazinobenzimidazole derivatives as probes for labelling human A1 and A2B adenosine receptor subtypes 111
Small Molecules Containing the Benzo[d]isotiazole Ring System as Novel ATP-Competitive Inhibitors of Epidermal Growth Factor Receptor protein Tyrosine Kinase 110
Arylsulfonamide inhibitors of aggrecanases as potential therapeutic agents for osteoarthritis: Synthesis and biological evaluation. 110
3-Aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one: a novel template for the design of highly selective A(2B) adenosine receptor antagonists 110
Translocator protein (tspo) ligand residence time: a new parameter to predict neurosteroidogenic efficacy for n,n-dialkyl-2-arylindol-3-ylglyoxylamides (PIGAs) 110
Microwave-assisted Suzuki Coupling in Aqueous Media: a Useful Tool for the Synthesis of 3-Arylindazole Derivatives 109
Translocator protein (TSPO) and identification of new molecular diagnosis tools 109
Antitumoral effect by induction of collapse of mitochondrial membrane potential in Glioblastoma Multiforme cells 109
Highlighting the new advances in drug discovery and development 109
Novel N-substituted indol-3-ylglyoxylamides probing the LDi and L1L2 lipophilic regions of the benzodiazepine receptor site in search for subtype-selective ligands 109
Anxiolytic properties of a 2-phenylindolglyoxylamide TSPO ligand: Stimulation of in vitro neurosteroid production affecting GABA(A) receptor activity 108
Lead Optimization of 2-Phenylindolylglyoxylyldipeptide Murine Double Minute (MDM)2/Translocator Protein (TSPO) Dual Inhibitors for the Treatment of Gliomas 108
3D-QSAR and virtual screening studies for the translocator protein(TSPO) 107
Novel Irreversible Fluorescent Probes Targeting the 18 kDa Translocator Protein: Synthesis and Biological Characterization 106
Synthesis and Biological Evaluation of Pyrido[1,2-d]pyrimidin-4-one Derivatives as Novel Aldose Reductase Inhibitors Exhibiting Antioxidant Activity 105
Novel Aldose Reductase Acetic acid Inhibitors Bearing a Five Membered heterocyclic core 105
3-Aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one: A Novel Template for the Design of Highly Selective A(2B) Adenosine Receptor Antagonists. 105
Long lasting MDM2/Translocator protein modulator: a new strategy for irreversible apoptosis of human glioblastoma cells 105
Benzothiopyranoindole- and pyridothiopyranoindole-based antiproliferative agents targeting topoisomerases 105
THIOAMIDE, IMINOTHIOETHER AND ISOTHIOCYANATE DERIVATIVES: CHEMOTYPES OF SLOW H2S-RELEASING AGENTS 103
Refinement of the Benzodiazepine Receptor Site Topology by Structure-Activity Relationships of New N-(Heteroarylmethyl)indol-3-ylglyoxylamides 103
A Virtual Screening Study of the 18 kDa Translocator Protein using Pharmacophore Models Combined with 3D-QSAR Studies 103
4-Substituted Benzenesulfonamides Incorporating Bi/Tricyclic Moieties Act as Potent and Isoform-Selective Carbonic Anhydrase II/IX Inhibitors 103
Rational Design and Synthesis of Potent and Selective Adenosine Receptor Antagonists 102
1-(PHENYLSULPHONAMIDO)-PYRAZOLE DERIVATIVES AS CARBONIC ANHYDRASE INHIBITORS. 102
Cell survival/death processes: Role of the mitochondrial Tranlocator Protein (TSPO) ligands 102
Synthesis and Evaluation of Translocator 18 kDa Protein (TSPO) Positron Emission Tomography (PET) Radioligands with Low Binding Sensitivity to Human Single Nucleotide Polymorphism rs6971 102
Geometrically Constrained Derivatives of Indolylglyoxylamides as Ligands Binding the GABAA/BzR Complex. 101
Totale 13.317
Categoria #
all - tutte 59.614
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.614


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.155 0 0 0 183 264 316 354 229 290 193 276 50
2020/20211.992 413 101 118 57 185 74 62 162 231 137 115 337
2021/20222.662 79 229 119 142 421 377 100 116 95 72 147 765
2022/20233.787 449 581 274 373 421 483 39 276 643 22 177 49
2023/20242.829 310 282 306 190 406 505 174 72 39 68 165 312
2024/2025516 60 286 103 67 0 0 0 0 0 0 0 0
Totale 22.491